CD7

CD7 Molekülinformation

Englischer Name	T-cell antigen CD7	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	32	Target-Alias	T-cell antigen CD7，GP40，CD7，TP41，CD7 Molecule，T-Cell Leukemia Antigen，T-Cell Surface Antigen Leu-9，CD7 Antigen (P41)，P41 Protein，CD7 Antigen，LEU-9，Tp40，Antigens， CD7
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	T-cell antigen CD7
Target-Alias	T-cell antigen CD7，GP40，CD7，TP41，CD7 Molecule，T-Cell Leukemia Antigen，T-Cell Surface Antigen Leu-9，CD7 Antigen (P41)，P41 Protein，CD7 Antigen，LEU-9，Tp40，Antigens， CD7
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	32
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

CD7 Produktliste

Attribut
Protein (19)Antibody (1)Cell Grade Beads (1)Cell (1)
Produktbibliothek
Online (21)In Forschung (1)
Spezies
Human (16)Mouse (2)Rabbit (1)Cynomolgus (3)
Etikett
Llama IgG Fc Tag (1)His Tag (12)His Tag & Avi Tag (2)Fc Tag & Avi Tag (2)Fc Tag (2)- (3)
Marker
Unconjugated (6)FITC Labeled (2)Biotin-labeled (5)PE Labeled (2)AF488 Labeled (2)APC Labeled (2)- (2)AF647 Labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HOT CD7-H5253	Human	HEK293	Human CD7 Protein, Fc Tag, low endotoxin (MALS verified)	In den Warenkorb legen
HOT CD7-H52H7	Human	HEK293	Human CD7 Protein, His Tag, low endotoxin (MALS verified)	In den Warenkorb legen
HOT CD7-H82E4	Human	HEK293	Biotinylated Human CD7 Protein, His,Avitag™, premium grade	In den Warenkorb legen
HOT CD7-HP2E3	Human	HEK293	PE-Labeled Human CD7 Protein, His Tag (Site-specific conjugation)	In den Warenkorb legen
CD7-H5258	Human	HEK293	Human CD7 Protein, Llama IgG2b Fc Tag, low endotoxin	In den Warenkorb legen
CD7-H82F3	Human	HEK293	Biotinylated Human CD7 Protein, Fc,Avitag™ (MALS verified)	In den Warenkorb legen
CD7-HA2H3	Human	HEK293	APC-Labeled Human CD7 Protein, His Tag (Site-specific conjugation)	In den Warenkorb legen
CD7-HA2H4	Human	HEK293	Alexa Fluor™ 647-Labeled Human CD7 Protein, His TagStar Staining	In den Warenkorb legen
CD7-HA2H6	Human	HEK293	APC-Labeled Human CD7 Protein, His TagStar Staining	In den Warenkorb legen
CD7-HA2H8	Human	HEK293	Alexa Fluor™ 488-Labeled Human CD7 Protein, His Tag	In den Warenkorb legen

Gesamtmenge22

CD7 Molekülalias

CD7,GP40,TP41,LEU-9,Tp40

Antikörperprojekt-Handelsplattform

Projektname	Projektphase	Molekültyp	Molekülquelle	Krankheitsgebiet	Indikationen
CD7 VHH - 01	Lead	Monoclonal	Nanobody	Hematological Malignancy	Non-hodgkin lymphoma

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Anti-CD7 and anti-CD19 chimeric antigen receptor T cell therapy	GC-197	Phase 2 Clinical	Gracell Biotechnologies (Shanghai) Co Ltd	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	Details
CLL1/CD33/CD38/CD7 CAR-T cell therapy		Phase 2 Clinical	Guangzhou Bio-Gene Technology Co Ltd	Leukemia, Myeloid, Acute	Details
BEAM-201	BEAM-201	Phase 2 Clinical	Beam Therapeutics Inc	Leukemia, Lymphoid; Leukemia, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
SupCD7 CART cells therapy (Institute Of Hematology & Blood Diseases Hospital)		Phase 2 Clinical	Institute Of Hematology & Blood Diseases Hospital	Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
CD7-specific CAR-T Cell therapy(Taihe Chunyu Biotechnology)		Phase 2 Clinical	Hebei Tahoe Chunyu Biotechnology Co Ltd	Hematologic Neoplasms; Lymphoma; Lymphoma, T-Cell	Details
CD7 CAR-T cell therapy(The General Hospital Of Western Theater Command)		Phase 2 Clinical	The General Hospital Of Western Theater Command	Leukemia	Details
CD5/CD7-Specific CAR-T Cells therapy(Essen Biotech)	BAH246; BAH-246; EB-BH2026	Phase 2 Clinical	Essen Biotech	Central Nervous System Diseases; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Autologous and Donor-derived CD7 CAR-T Therapy(Beijing GoBroad Hospital)		Phase 2 Clinical	Beijing GoBroad Hospital	Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
CD7-CAR-T Cells Therapy	CD7-CART01	Phase 2 Clinical	Bambino Gesu Hospital And Research Institute	Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
RD-13	RD13-02; RD 13 02; RD-13; RD-13-01; CTD-401; CTD-402	Phase 2 Clinical	Nanjing Bioheng Biotech Co Ltd	Anemia, Aplastic; Diabetes Mellitus, Type 1; Hematologic Diseases; Hematologic Neoplasms; Lymphoma, Extranodal NK-T-Cell; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Humanized CD7 CAR-T cells		Phase 2 Clinical	The First Affiliated Hospital Of Soochow University	Lymphoma, T-Cell	Details
Soficabtagene Geleucel	WU-CART-007	Phase 2 Clinical	Wugen Inc	Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome	Details
SenL-T7 CAR T Cells (Hebei Senlang Biological)	Senl-T7; Senl-T-7; SENL-101	Phase 2 Clinical	Hebei Senlang Biological Technology Co Ltd	Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T lymphoblastic lymphoma	Details
PA3-17	PA3-17	Phase 2 Clinical	Persongen Biotherapeutics (Suzhou) Co Ltd	Hematologic Neoplasms; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; T lymphoblastic lymphoma	Details
CD7 CAR-T cell therapy (Hebei Senlang Biotechnology)		Phase 2 Clinical	Hebei Senlang Biological Technology Co Ltd	Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Anti-CD7 CAR T-cell therapy (Yake Biotechnology)		Phase 2 Clinical	Shanghai YaKe Biotechnology Co Ltd	Anemia, Aplastic; Autoimmune Diseases; Bone Marrow Failure Disorders; Colitis, Ulcerative; Crohn Disease; Dermatomyositis; Hematologic Diseases; Leukemia; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; Neoplasms; Osteochondrodysplasias; Still's Disease, Adult-Onset	Details
CD7.CAR/28zeta CAR T cells		Phase 1 Clinical	Baylor College Of Medicine	Angioimmunoblastic T-cell Lymphoma; Leukemia, Prolymphocytic; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome	Details
GC-027	GC-027	Phase 1 Clinical	Gracell Biotechnologies (Shanghai) Co Ltd	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
UTAA-07	UTAA-07; UTAA07	Phase 1 Clinical	Persongen Biotherapeutics (Suzhou) Co Ltd	Hematologic Neoplasms	Details
JY-008	JY008; JY-008	Phase 1 Clinical	Institute Of Hematology & Blood Diseases Hospital	Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Anti CD7 CAR-T cells therapy (Peking University People'S Hospital)		Phase 1 Clinical	Peking University People'S Hospital	Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
QH-106	QH106; QH-106	Phase 1 Clinical	Anhui Provincial Hospital	Leukemia	Details
Anti-human CD7 CAR-NK cell Therapy(Shanghai General Hospital)		Phase 1 Clinical	Shanghai Jiao Tong University Affiliated First People'S Hospital	Hematologic Neoplasms; Immune System Diseases	Details
uCD7 CART cell therapy (Institute Of Hematology & Blood Diseases Hospital)		Phase 1 Clinical	Institute Of Hematology & Blood Diseases Hospital	Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
VGO-Cs01p	VGO-Cs01p	Phase 1 Clinical	Shanghai Vitalgen BioPharma Co Ltd	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Details
MB-107(March Biosciences)	MB-107(March Biosciences)	Phase 1 Clinical	March Biosciences Inc	Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Anti-CD7 Chimeric Antigen Receptor T-Cell therapy(Bioceltech Therapeutics)	BT-007	Phase 1 Clinical	Bioceltech Therapeutics Ltd, Gracell Biotechnologies (Shanghai) Co Ltd	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
BE CAR-7	BE-CAR-7	Phase 1 Clinical	Great Ormond Street Hospital For Children Nhs Foundation Trust	Leukemia, Prolymphocytic, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Anti-CD7 CAR-T cell Therapy (Shanghai Jiao Tong University Affiliated First People'S Hospital)		Phase 1 Clinical	Shanghai Jiao Tong University Affiliated First People'S Hospital	Angioimmunoblastic T-cell Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
Anti-CD19/CD7 UCAR-T cell therapy (Gracell)	GC-502	Phase 1 Clinical	Gracell Biotechnologies (Shanghai) Co Ltd	Lymphoma, Non-Hodgkin; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	Details
CD7 CARvac T cell therapy (iCell Gene Therapeutics)		Phase 1 Clinical	Icell Gene Therapeutics (Int'L) Ltd	Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details
PCART7-CD3	PCART7-CD3	Clinical	National University Of Singapore	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	Details

Produktrezensionen

A***e2026-06-05
0Menschen mögen
Human CD7 Protein, Fc Tag, low endotoxin (MALS verified)
We used CD7 for our SPR assays. The antigen was of good quality, well-behaved, and arrived quickly for our urgent need. I appreciate Acro's suite of QC data provided with each antigen. We appreciate Acro as a reliable source for our protein needs.
J***n2023-06-16
1Menschen mögen
PE-Labeled Human CD7 Protein, His Tag (Site-specific conjugation)
We ordered some Human CD7 Protein and I was whole heartedly impressed with the packaging and support from Acro when I requested some information.